Enveric Biosciences Announces Positive Results from Recently Completed IND-enabling ADMET Studies
CAMBRIDGE, Mass., October 21, 2026--Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address…





